Comparison of treatment regimens for unresectable stage III epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer

Durvalumab after chemoradiotherapy (CRT) failed to bring survival benefits to patients with epidermal growth factor receptor (EGFR) mutations in PACIFIC study ( evaluating durvalumab in patients with stage III, unresectable NSCLC who did not have disease progression after concurrent chemoradiotherap...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Chinese medical journal 2024-12
Hauptverfasser:	Dai, Xin, Xu, Qian, Sheng, Lei, Zhang, Xue, Huang, Miao, Li, Song, Huang, Kai, Chu, Jiahui, Wang, Jian, Li, Jisheng, Liu, Yanguo, Zhou, Jianyuan, Nie, Shulun, Liu, Lian
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!